Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations
Current Issues in Molecular Biology · 26.04.2025 · 47 (5) · 303
DOI: 10.3390/cimb47050303 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 26.04.2025. Verfasst von Muhammad Awais Ashraf und 9 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Molecular Virology & Immunology, Institutional Center for Shared Technologies and Facilities, Pathogen Discovery and Preservati…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the Technical Support Talent Project from Chinese Academy of Sciences and Open foundation of National Virus Resource Center, grant…, Technical Support Talent Project from the Chinese Academy, Open foundation of National Virus Resource Center.
Abstract (Originalsprache)
Albumin is the most abundant plasma protein, accounting for approximately 50% of total serum protein in healthy individuals. In recent years, albumin has attracted significant attention due to its biocompatibility, non-toxicity (metabolizing in vivo into harmless degradation products), non-immunogenic properties, ease of purification, and water solubility. These characteristics render it an ideal candidate for a wide range of biomedical applications. Its uses include drug delivery systems, wound healing, antioxidant therapies, infusion treatments, COVID-19 therapeutics, tissue engineering, and other critical care domains. Consequently, the global demand for albumin has been steadily increasing. The international albumin market was valued at USD 5394.9 million in 2021 and is projected to reach USD 9192 million by 2030, with a compound annual growth rate (CAGR) of 6.1%. Given its diverse applications and rising demand, substantial efforts have been made to ensure a sustainable supply of albumin. This review provides an overview of albumin, along with its novel applications, purification methods, and market trends.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CAS Key Laboratory of Molecular Virology & Immunology, Institutional Center for Shared Technologies and Facilities, Pathogen Discovery and Preservation Platform, Shanghai Institute of Immunity and Infection, Chinese Aca…
- University of Chinese Academy of Sciences, Beijing 101408, China.
- Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai 200093, China.
- Department of Chemistry, The University of Lahore, Lahore 54590, Pakistan.
ORCID-Profile: Muhammad Nabeel Amjad, Yihong Hu
Förderung
- This research was funded by the Technical Support Talent Project from Chinese Academy of Sciences and Open foundation of National Virus Resource Center, grant…
- Technical Support Talent Project from the Chinese Academy
- Open foundation of National Virus Resource Center
Zitieren
APA
Ashraf, M. A., Shen, B., Raza, M. A., Yang, Z., Amjad, M. N., Din, G. U., Yue, L., Kousar, A., Kanwal, Q., & Hu, Y. (2025). Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations. Current Issues in Molecular Biology, 47(5), 303. https://doi.org/10.3390/cimb47050303
Vancouver
Ashraf MA, Shen B, Raza MA, Yang Z, Amjad MN, Din GU, et al. Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations. Current Issues in Molecular Biology. 2025;47(5):303. doi:10.3390/cimb47050303
BibTeX
@article{Ashraf2025,
author = {Ashraf, Muhammad Awais and Shen, Bei and Raza, Muhammad Asif and Yang, Zhu and Amjad, Muhammad Nabeel and Din, Ghayyas Ud and Yue, Lihuan and Kousar, Afifa and Kanwal, Qudsia and Hu, Yihong},
title = {Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {5},
pages = {303},
doi = {10.3390/cimb47050303}
}
EUVIMED